Dasarraju Rupak Kumar, Svsg Nirmala
Department of Pedodontics and Preventive Dentistry, Priyadarshini Dental College & Hospital, Pandur, Thirivallur, Tamilnadu, India.
Department of Pedodontics and Preventive Dentistry, Narayana Dental College & Hospital, Nellore, India.
J Dent Anesth Pain Med. 2020 Feb;20(1):29-37. doi: 10.17245/jdapm.2020.20.1.29. Epub 2020 Feb 28.
This study evaluated the efficacy of three intraoral topical anesthetics in reducing the injection needle prick pain from local anesthetic among children aged 7-11 years old.
It is a prospective, Interventional, parallel design, single-blind, randomized clinical trial in which subjects (n=90) aged 7-11 years were included in the study based on an inclusion criteria. Subjects were divided into three groups based on computer-generated randomization with an allocation ratio of 1:1:1. Groups A, B, and C received benzocaine 20% jelly (Mucopain gel, ICPA health products Ltd, Ankleshwar, India), cetacaine anesthetic liquid (Cetylite Industries, Inc, Pennsauken, NJ), and EMLA cream (2% AstraZeneca UK Ltd, Luton, UK), respectively, according to manufacturer's instructions, for 1 minute prior to local anesthetic injection. After application of topical anesthetic agent, for all the groups, baseline pre-operative (prior to topical anesthetic administration) and post-operative scores (after local anesthetic administration) of pulse rate was recorded using Pulse oximeter (Gibson, Fingertip Pulse Oximeter, MD300C29, Beijing Choice Electronic). Peri-operative (i.e., during the administration of local anesthesia) scores were recorded using Face, Legs, Activity, Cry, Consolability (FLACC) Scale, Modified Children hospital of Eastern Ontario Pain Scale (CPS) behavior rating scale, and Faces Pain Scale (FPS-R) - Revised (For self-reported pain). Direct self-reported and physiological measures were ascertained using FPS-R - Revised and Pulse oximeter, respectively, whereas CPS and FLACC scales assessed behavioral measures. To test the mean difference between the three groups, a one way ANOVA with post hoc tests was used. For statistical significance, a two-tailed probability value of P < 0.05 was considered as significant.
The Cetacaine group had significantly lower pain scores for self-report (P < 0.001), behavioral, and physiological measures (P < 0.001) than the other two groups. However, there was no significant difference between the Benzocaine group and EMLA group during palatal injection prick.
Cetacaine can be considered as an effective topical anesthetic agent compared to benzocaine 20% jelly (Mucopain gel) and EMLA cream.
本研究评估了三种口腔局部麻醉剂在减轻7至11岁儿童局部麻醉注射针刺痛方面的疗效。
这是一项前瞻性、干预性、平行设计、单盲、随机临床试验,根据纳入标准纳入了90名7至11岁的受试者。根据计算机生成的随机分组,受试者被分为三组,分配比例为1:1:1。A组、B组和C组分别按照制造商的说明,在局部麻醉注射前1分钟使用20%苯佐卡因凝胶(Mucopain凝胶,ICPA健康产品有限公司,印度安克利什瓦尔)、西他卡因麻醉液(Cetylite Industries公司,新泽西州彭索肯)和复方利多卡因乳膏(2%,阿斯利康英国有限公司,卢顿,英国)。在使用局部麻醉剂后,对所有组使用脉搏血氧仪(吉布森,指尖脉搏血氧仪,MD300C29,北京卓诚电子)记录术前(局部麻醉剂给药前)和术后(局部麻醉剂给药后)的脉搏率基线值。使用面部、腿部、活动、哭闹、安慰度(FLACC)量表、改良的安大略东部儿童医院疼痛量表(CPS)行为评定量表和面部疼痛量表(FPS-R)修订版(用于自我报告疼痛)记录围手术期(即局部麻醉给药期间)的评分。直接自我报告和生理测量分别使用FPS-R修订版和脉搏血氧仪确定,而CPS和FLACC量表评估行为测量。为了检验三组之间的平均差异,使用了单因素方差分析和事后检验。对于统计学显著性,双侧概率值P < 0.05被认为具有显著性。
西他卡因组在自我报告(P < 0.001)、行为和生理测量(P < 0.001)方面的疼痛评分显著低于其他两组。然而,在腭部注射刺痛期间,苯佐卡因组和复方利多卡因乳膏组之间没有显著差异。
与20%苯佐卡因凝胶(Mucopain凝胶)和复方利多卡因乳膏相比,西他卡因可被认为是一种有效的局部麻醉剂。